Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging-Reference-Cited by-同舟云学术

Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging

Published:2011-03-01 Issue:3 Volume:96 Page:665-671
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Abgral Ronan¹,Leboulleux Sophie²,Déandreis Désirée²,Aupérin Anne³,Lumbroso Jean²,Dromain Clarisse⁴,Duvillard Pierre⁵,Elias Dominique⁶,de Baere Thierry⁴,Guigay Joël⁷,Ducreux Michel⁸,Schlumberger Martin²,Baudin Eric²

Affiliation:

1. Department of Nuclear Medicine (R.A.), University Hospital of Brest, 29200 Brest, France;

2. Department of Nuclear Medicine and Endocrine Tumors (S.L., D.D., J.L., M.S., E.B.), Institut Gustave Roussy, Universite Paris Sud, 94800 Villejuif, France;

3. Department of Epidemiology (A.A.), Institut Gustave Roussy, 94800 Villejuif, France;

4. Department of Radiology (C.D., T.d.B.), Institut Gustave Roussy, 94800 Villejuif, France;

5. Department of Pathology (P.D.), Institut Gustave Roussy, 94800 Villejuif, France;

6. Department of Oncologic Surgery (D.E.), Institut Gustave Roussy, Universite Paris Sud, 94800 Villejuif, France

7. Department Medical Oncology (J.G.), Institut Gustave Roussy, Universite Paris Sud, 94800 Villejuif, France

8. Department Digestive Oncology (M.D.), Institut Gustave Roussy, Universite Paris Sud, 94800 Villejuif, France

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/96/3/665/9067548/jcem0665.pdf

Reference36 articles.

1. Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: somatostatin receptor imaging with (111)In-pentetreotide.;Kwekkeboom;Neuroendocrinology,2009

2. Gastroenteropancreatic endocrine tumors: clinical characterization before therapy.;Baudin;Nat Clin Pract Endocrinol Metab,2007

3. Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.;Faggiano;Cancer,2007

4. Somatostatin, cortistatin and their receptors in tumours.;Volante;Mol Cell Endocrinol,2008

5. Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?;Schillaci;J Nucl Med,2007

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Management of Neuroendocrine Tumour Liver Metastases;Current Oncology Reports;2024-06-13

2. CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms;Cancers;2024-05-08

3. Neuroendocrine neoplasms of the lung;Practical Pulmonary Pathology;2024

4. Definition of Radioactive Iodine Refractory Thyroid Cancer and Redifferentiation Strategies;Integrated Diagnostics and Theranostics of Thyroid Diseases;2023

5. Diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms by nuclear medicine: Update and future perspective;Frontiers in Oncology;2022-11-22